Ads
related to: johnson and johnson stock price- Latest news
The latest financial news.
Learn more from J&J.
- Quarterly results
Get information about
J&J's quarterly results.
- Latest news
Search results
Are You Looking for a High-Growth Dividend Stock?
Zacks via Yahoo Finance· 7 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what...
Sarepta Therapeutics stock to enter S&P MidCap 400: Should you buy? | Invezz
Invezz· 6 days agoThis change, effective before trading begins on June 3, 2024, follows Johnson & Johnson’s...
J&J-backed Rapport Therapeutics seeks about $637 million valuation in US IPO
Reuters via Yahoo News· 2 days agoThe U.S. IPO market is staging a strong comeback after two dismal years, thanks to a rally in the stock market and growing optimism of a possible interest ...
Silicon Laboratories CEO sells shares worth over $895k By Investing.com
Investing.com· 18 hours agoSilicon Laboratories Inc. (NASDAQ:SLAB) President and CEO Robert Matthew Johnson has sold a portion...
Target's poor Pride Month decision proves companies can’t have it both ways
The Advocate· 2 days agoAt agencies, I also worked with brands including Johnson & Johnson, Disney, Dunkin’ Donuts, and...
7 Overlooked Stocks That Belong in Every Portfolio
InvestorPlace· 2 days agoOverlooked stocks are not necessarily underperforming the market. In some cases, these stocks simply are slow and steady at a time when investors want to...
Why Sarepta Therapeutics Stock Is Rising Today - Sarepta Therapeutics (NASDAQ:SRPT)
Benzinga· 6 days agoSarepta Therapeutics, Inc. SRPT stock is trading higher on Thursday after it was announced the...
J&J-backed Rapport Therapeutics seeks about $637 million valuation in US IPO
AOL· 2 days agoThe U.S. IPO market is staging a strong comeback after two dismal years, thanks to a rally in the stock market and growing optimism of a possible interest ...
Exelixis director and Caligan Partners LP buy $8.73 million in shares By Investing.com
Investing.com· 5 days agoIn a recent move, David Edward Johnson, a director at Exelixis, Inc. (NASDAQ:EXEL), and investment...
Only 49 companies have been on the Fortune 500 for all 70 years. Here are their secrets to staying...
Fortune via AOL· 19 hours agoBut the 49ers mostly do what their powerful core drives them to do, and the world adapts to them....
Ad
related to: johnson and johnson stock price